BioCorRx BICX
OTC BICX
$0.20 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

BioCorRx (BICX) Other Accumulated Expenses (2011 - 2026)

Updated

BioCorRx's Other Accumulated Expenses came in at $94,816 for Q1 2026.

Analysis

BioCorRx (BICX) Other Accumulated Expenses (2011 - 2026) Analysis & Trends

At the end of FY2022, BioCorRx's Other Accumulated Expenses was $990,637.

  • The Q1 2026 figure represents the highest quarterly Other Accumulated Expenses since Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 BioCorRx 830.00 -906,148.00 -56,997.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 45,146.00
Mar 31, 2026 94,816.00
Dec 31, 2025 43,382.00
Sep 30, 2025 15.04 Mn
Jun 30, 2025 41,686.00
Mar 31, 2025 40,863.00
Dec 31, 2024 40,057.00
Sep 30, 2024 39,266.00
Jun 30, 2024 38,491.00
Mar 31, 2024 104,062.00
Dec 31, 2023 122,732.00
Sep 30, 2023 146,187.00
Jun 30, 2023 142,160.00
Mar 31, 2023 1.19 Mn
Dec 31, 2022 990,637.00
Sep 30, 2022 130,559.00
Jun 30, 2022 126,876.00
Mar 31, 2022 123,269.00
Dec 31, 2021 119,733.00
Sep 30, 2021 116,276.00
API Access

BioCorRx Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BICX&period=max&api_key=YOUR_API_KEY